Paglinawan, Vilma G.

HRN: 29-11-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/11/2026
06/18/2026
IV
2.25g
Q6
Skin And Soft Tissue Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines